Request for Covid-19 Impact Assessment of this Report
Fetal care and treatment of neonates are a standout amongst the most challenging tasks conceivable because of its one of a kind physiological and developmental needs. Fetal and neonatal monitoring is key in conveying life-maintaining, non-intrusive, and developmentally supportive care to neonates and in giving a tranquil and quiet condition to secure the improvement of the baby. Thus, there is a high demand for these products with low cost or locally manufactured products with safety as the primary criteria.
End-user/Technology
The top users of this technology are mostly from Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies), diagnostic centers & research institutes.
Market Dynamics
Global Fetal And Neonatal Monitoring Market are expected to grow at a CAGR of 7.1 % for the next decade. Some factors such as the increasing prevalence of hospital-acquired infections in newborn babies and large patient populaces of preterm and low weight birth babies in both developed and developing markets interest for neonatal care gear, thus, stimulating the development of the neonatal care hardware market. Again, premature and congenitally ill infants are born as a result of advanced maternal age, induced fertility, labor treatments, inadequate prenatal care, and changes in lifestyle preferences. Various disorders like anemia, bronchopulmonary dysplasia, intraventricular hemorrhage are diagnosed at the time of birth, and this aide in the development of the fetal and neonatal care market.
Market Segmentation
Global Fetal And Neonatal Monitoring Market can be segmented based on type of equipment used for neonatal (ventilators, incubators, phototherapy) and fetal (heart rate monitors, pulse oximeters, intrauterine pressure, catheters, fetal doppler, uterine contraction monitor), in-house monitoring, portability (portable, non-portable), method (invasive, non-invasive), software solutions (user-friendly), application (antepartum, intrapartum), users (hospitals, clinics) and geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa).
Regional/Geographic Analysis
Geographically, the global neurology monitoring market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. As of 2015, North America (comprising the U.S. and Canada) held the most significant share of the worldwide fetal and neonatal care equipment market. A few factors, for example, the presence of a superior repayment structure, the accessibility of specialists (neonatologists) and all around prepared NICU (Neonatal Intensive-Care Unit) focuses are driving the development of the fetal and neonatal care hardware to advertise in North America. Be that as it may, the Asia-Pacific fetal and neonatal care equipment market is relied upon to witness the most astounding development in the conjecture time frame. Rising activities by different private and government associations for directing awareness projects to enhance neonatal care and rising birth rates in Asia-Pacific nations are some of the noteworthy components developing the interest for fetal and neonatal care equipment in the Asia-Pacific area.
Opportunities
The growing popularity of fetal MRI, technological innovations and the high demand for portable and versatile systems are some of the prospects for the market players. However, they face the challenges of increasing product recalls and lack of awareness and economic constraints in developing countries. The growth drivers could be rising incidence of preterm birth, increasing awareness of prenatal and neonatal care, increased demand for prenatal therapeutics, diagnostics, and monitoring devices and government initiatives to provide better care for prenatal and neonatal infants
Key Players
Some of the key players in the market are E Healthcare (U.K.), Philips Healthcare (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Medtronic plc (Ireland), Masimo Corporation (U.S.), CareFusion Corporation, Cooper Surgical, Inc., Covidien PLC, Fisher & Paykel Healthcare Limited, FUJIFILM SonoSite, Inc., Getinge AB, Nonin Medical, Inc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...